ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

ONCC Says 1,480 Nurses Passed Certification Exam

January 6, 1989

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

Nutrition May Get An Extra 44 Million In FY 1979; Program Announcement Describes Opportunities

September 22, 1978

No Cancer Letter For Next Two Weeks

August 30, 1991

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003